Open AccessMultiple Evanescent White Dot Syndrome: A Case Report and Experience with Corticosteroid Therapy
Author(s) -
Amir Hossein Norooznezhad,
Vahid Mohammadzadeh,
Sakineh Kadivar,
Fariba Ghassemi
Publication year - 2020
Publication title -
iranian journal of allergy, asthma and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 1735-5249
pISSN - 1735-1502
DOI - 10.18502/ijaai.v19i(s1.r1).2865
Subject(s) - blind spot , medicine , visual acuity , presentation (obstetrics) , choroid , retinal pigment epithelium , ophthalmology , central scotoma , triamcinolone acetonide , corticosteroid , prednisolone , snellen chart , retina , optometry , retinal , surgery , psychology , artificial intelligence , computer science , neuroscience
Multiple evanescent white dot syndrome (MEWDS) is an inflammatory eye disease of the outer retina, retinal pigmented epithelium, choroid presenting with photopsia, loss of vision, and temporal scotoma. The patient was a 31-year-old female with a history of vision loss since 11 days ago (left eye). At presentation, best-corrected Snellen visual acuity was 20/140 in the Snellen chart. We decided to treat her with short time corticosteroid therapy (0.75 mg/kg/day prednisolone which was tapered in 3 weeks) for any possible rapid recovery of vision. The visual acuity of the involved eye was improved to 20/25 and 20/20, one week and three weeks after starting treatment respectively. Thus, it seems that short-term oral steroids might be an alternative method of management for patients with MEWDS.